Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer



Anticancer Drug Targets of Salvia Phytometabolites: Chemistry, Biology and Omics

Volume:19   Issue: 1
Pp: 1-20
Da-Cheng Hao*, Guang-Bo Ge and Pei-Gen Xiao
DOI: 10.2174/1389450117666161207141020




PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials

Volume:19   Issue: 1
Pp: 21-37
Dalia Kamel*, Christopher Gray, Jagdeep Singh Walia and Vikaash Kumar*
DOI: 10.2174/1389450118666170711151518




Cytochrome P450 Structure, Function and Clinical Significance: A Review

Volume:19   Issue: 1
Pp: 38-54
Palrasu Manikandan and Siddavaram Nagini*
DOI: 10.2174/1389450118666170125144557




The Hot and Potential Targets of Type 2 Diabetes Mellitus Treatment in Recent Decade

Volume:19   Issue: 1
Pp: 55-69
Qi Xu, Lijun Wang, Jiao Luo and Dayong Shi*
DOI: 10.2174/1389450118666170307111714




Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer

Volume:19   Issue: 1
Pp: 70-80
Md Abul Barkat, Harshita, Javed Ahmad, Mohammad Ahmed Khan*, Sarwar Beg* and Farhan Jalees Ahmad*
DOI: 10.2174/1389450118666170612095959




Idarucizumab: What Should We Know?

Volume:19   Issue: 1
Pp: 81-88
Francesca Cortese*, Giacinto Calculli, Michele Gesualdo, Annagrazia Cecere, Annapaola Zito, Fiorella De Vito, Rossella Carbonara, Santa Carbonara, Anna Maria Cortese and Marco Matteo Ciccone
DOI: 10.2174/1389450118666170925155943




Antitumor Activity of Polysaccharides: An Overview

Volume:19   Issue: 1
Pp: 89-96
Ling Chen and Gangliang Huang*
DOI: 10.2174/1389450118666170704143018